SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Dino's Bar & Grill

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Goose94 who wrote (48974)10/30/2019 8:00:03 PM
From: Goose94Read Replies (1) of 203627
 
Hamilton Thorne (HTL-V) top pick from Don Lato on BNN.ca Market Call Wed Oct 30th @ 1200ET

Hamilton Thorne is among the 10 largest companies in the very fragmented global in-vitro fertilization (IVF) industry. The two largest companies control approximately 30 per cent of the $1-billion IVF market, with HTL projected to have sales in the $50-million area next year. For a multitude of reasons, the industry is expected to enjoy 5 to 10 per cent organic revenue growth over the next several years. HTL has grown organically and through acquisitions and there are a number of smaller players that could be acquired at very low valuations that would be accretive to HTL’s earnings growth. The company trades a very reasonable enterprise value to earnings before interest, taxes, depreciation and amortization (EBITDA) multiple of 10.8 times 2020 EBITDA compares very well to the industry leader Vitrolife AB at approximately 30 times.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext